POLYCLONAL MONOCLONAL RATIO IN KIDNEY AND BONE-MARROW TRANSPLANTED PATIENTS TREATED WITH CYCLOSPORINE/

Citation
D. Capone et al., POLYCLONAL MONOCLONAL RATIO IN KIDNEY AND BONE-MARROW TRANSPLANTED PATIENTS TREATED WITH CYCLOSPORINE/, Clinical transplantation, 12(5), 1998, pp. 430-433
Citations number
13
Categorie Soggetti
Surgery,Transplantation
Journal title
ISSN journal
09020063
Volume
12
Issue
5
Year of publication
1998
Pages
430 - 433
Database
ISI
SICI code
0902-0063(1998)12:5<430:PMRIKA>2.0.ZU;2-1
Abstract
On 296 blood samples obtained from 22 bone marrow and 21 kidney transp lanted patients, the concomitant measurements of polyclonal and monocl onal cyclosporine (CsA) were performed and the relative polyclonal/mon oclonal (P/M) ratios were calculated. Biochemical profiles of kidney a nd liver functions were also determined in all patients. For each type of transplant, biochemical data were divided into two subgroups on th e basis of P/M ratio: A) data obtained in patients with P/M ratio > 3. 0; B) data obtained in patients with P/M ratio less than or equal to 3 .0. While in kidney transplanted patients no difference of biochemical profiles was found between two subgroups, in bone marrow transplant r ecipients the subgroup A showed a worsening of hepatic function parame ters as compared to subgroup B. Therefore, it appears that P/M ratio c ould represent in bone marrow transplantation an index of hepatic CsA toxicity.